114 results
DEFM14A
ORTX
Orchard Therapeutics plc
16 Nov 23
Proxy related to merger
4:45pm
effects, adverse events or safety observations, in each of (A) – (F), solely to the extent not resulting from or arising out of any wrongdoing, fraud … , process, summarize and report financial information and (B) any fraud, whether or not material, that involves management or other employees who have
PREM14A
ORTX
Orchard Therapeutics plc
3 Nov 23
Preliminary proxy related to merger
5:11pm
wrongdoing, fraud or intentional misconduct or misrepresentation, any violation of any applicable law, or any negligent or reckless actions … and (B) any fraud, whether or not material, that involves management or other employees who have a significant role in Apple’s internal control over
DEFA14A
8m1ol7 5f
5 Oct 23
Additional proxy soliciting materials
9:07am
8-K
EX-2.1
dthmta4j d0m
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
8-K
EX-10.1
rmc2b1v 6uie5
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
424B3
tm485
21 Aug 23
Prospectus supplement
4:32pm
S-8
EX-5.1
0eonc5qb7nixfl jx
10 Aug 23
Registration of securities for employees
5:04pm